|本期目录/Table of Contents|

[1]吴崑,严红丽,张卫国.肠易激综合征患者应用双歧杆菌四联活菌联合谷维素治疗的疗效观察[J].医学研究与战创伤救治(原医学研究生学报),2016,18(04):398-401.[doi:10.3969/j.issn.1672-271X.2016.04.019]
 WU Kun,YAN Hong-li,ZHANG Wei-guo..The effect of irritable bowel syndrome patients with application ofbifidobacterium tetravaccine tablets and oryzanol[J].JOURNAL OF MEDICALRESEARCH —COMBAT TRAUMA CARE,2016,18(04):398-401.[doi:10.3969/j.issn.1672-271X.2016.04.019]
点击复制

肠易激综合征患者应用双歧杆菌四联活菌联合谷维素治疗的疗效观察()

《医学研究与战创伤救治》(原医学研究生学报)[ISSN:1672-271X/CN:32-1713/R]

卷:
第18卷
期数:
2016年04期
页码:
398-401
栏目:
出版日期:
2016-08-20

文章信息/Info

Title:
The effect of irritable bowel syndrome patients with application ofbifidobacterium tetravaccine tablets and oryzanol
作者:
吴崑1严红丽2张卫国3
1. 442000湖北十堰,十堰市东汽公司花果医院内科;2. 442000湖北十堰,湖北医药学院附属东风医院儿童医疗中心儿科;3. 442000湖北十堰,湖北医药学院
Author(s):
WU Kun1 YAN Hong-li2 ZHANG Wei-guo3.
1. Department of Medicine, Huaguo Hospital of Dongfeng Motor Corporation, Shiyan, Hubei 442000, China;2.Department of Pediatrics, Childrens Medical Center, Dongfeng Hospital, Hubei University of Medicine, Shiyan, Hubei 442000, China;3.Hubei University of Medicine, Shiyan, Hubei 442000, China
关键词:
肠易激综合征双歧杆菌四联活菌谷维素
Keywords:
irritable bowel syndrome bifidobacterium tetravaccine tablets(live) oryzanol
分类号:
R574.4
DOI:
10.3969/j.issn.1672-271X.2016.04.019
文献标志码:
A
摘要:
目的 探讨肠易激综合征患者应用双歧杆菌四联活菌联合谷维素治疗的效果。方法 采用随机分组的方法,将本院接收的384例肠易激综合征患者分为对照组和实验组,每组各192例。其中对照 组给予匹维溴胺及谷维素口服,实验组在对照组治疗的基础上加用双歧杆菌四联活菌口服,分别观察比较分析两组患者治疗前后精神评分、消化道症状评分、治疗效果及不良反应发生情况。结果 治疗 后两组患者各亚型焦虑量表、抑郁量表评分及消化道症状评分均低于治疗前(P<0.05);实验组各亚型治疗后焦虑量表评分、抑郁量表评分及消化道症状评分均显著低于对照组(P<0.05)。对照组总 有效率为71.88%,实验组总有效率为90.63%,其中腹泻型及腹泻便秘交替型,实验组明显高于对照组(P<0.05)。两组均有患者出现轻微不良反应,对照组头痛、乏力4例,恶心2例,实验组头痛、乏 力及恶心均有2例,经对症治疗后症状均消失。结论 应用双歧杆菌四联活菌联合谷维素治疗肠易激综合征患者疗效显著,不良反应少,值得临床推广。
Abstract:
Objective To explore the effect of irritable bowel syndrome patients with application of bifidobacterium tetravaccine tablets(live) and oryzanol. Methods 384 cases of patients with irritable bowel syndrome were selected and randomly divided into two groups. Control group gave pinaverium bromide and oryzanol, and the experimental group used bifidobacterium tetravaccine tablets(live) on the basis of control group. Mental score, enteron symptom scores, therapeutic effect and adverse reactions were detected before and after treatment and compared between two groups. Results After treatment, patients with anxiety scale, depression rating scale and the digestive tract symptom scores were lower than before treatment in the two groups (P<0.05). After treatment, anxiety rating scale, depression rating scale and the digestive tract symptom scores of the experimental group were significantly lower than control group (P<0.05). The total effective rate of control group was 71.88%, the experimental group was 90.63%, and the experimental group was significantly higher than control group (P<0.05).Two groups had mild adverse reactions, and the control group had 4 cases with headache and weakness, 2 case with nausea; the experimental group had 2 case with headaches, fatigue and 2 case with nausea.The adverse reaction were disappeared after symptomatic treatment. Conclusion Irritable bowel syndrome patients with application of bifidobacterium tetravaccine tablets(live) joint oryzanol has obvious therapeutic effect, less adverse reactions, and it is worthy of clinical promotion.

参考文献/References:

[1]罗群,郑丽容,刘华珍,等.双歧杆菌四联活菌片治疗儿童和青少年肠易激综合征的疗效观察[J].中国药师,2011,14(12):1767-1768.
[2]杨文伟,潘珍红.双歧杆菌四联活菌片对肠易激综合征患者血清 P物质和神经肽Y水平的影响及疗效观察[J].中国药师,2015,(5):794-796. [3]郭晓鹤,张彩凤,朱艳丽,等.芪倍合剂与双歧杆菌四联活菌片联用治疗肠易激综合征临床研究[J].中医学报,2014,29(2):288-290.
[4]梁育飞,田树英.氟哌塞吨美利曲辛联合双歧杆菌四联活菌治疗腹泻型肠易激综合征患者免疫指标的变化及意义[J].临床荟萃,2013,28(5):559-561.
[5]吴蓉,姒健敏,王侃,等.匹维溴铵联合双歧杆菌三联活菌和多塞平治疗腹泻型肠易激综合征的疗效分析[J].中国医师进修杂志,2011,34(19):1-4.
[6]Patel MM, Amin AF. Process, optimization and characterization of mebeverine hydrochloride loaded guar gum microspheres for irritable bowel syndrome[J].Carbohydr Polym:Scientif Technolog Asp Industr Import Polysacchar,2011,86(2):536-545.
[7]张璐,段丽萍,刘懿萱,等.中国人群肠易激综合征患病率和相关危险因素的Meta分析[J].中华内科杂志,2014,53(12):969-975.
[8]陈叶青,周国华,周红宇,等.文拉法辛联合马来酸曲美布汀及双歧三联活菌治疗难治性肠易激综合征的疗效观察[J].中国全科医学,2011,14(5):547-549.
[9]胡乐义,王巧民,姜彬言,等.肠易激综合征患者肠道菌群的变化及意义[J].安徽医科大学学报,2012,47(1):86-89.
[10]Quigley EM,Abdel-Hamid H,Barbara G, et al.A global perspective on irritable bowel syndrome: A consensus statement of the world gastroenterology organisation summit task force on irritable bowel syndrome[J].J Clin Gastroenterol, 2012,46(5):356-366.
[11]陈寒昱,孙志广.肠易激综合征发病机制研究进展[J].东南大学学报(医学版),2012,31(2):243-245.
[12]沈宏.氟哌噻吨美利曲辛联合双歧三联活菌治疗肠易激综合征疗效观察[J].中国基层医药,2011,18(1):78-79.
[13]胡玥,陶丽媛,吕宾,等.益生菌制剂治疗肠易激综合征的Meta分析[J].中华内科杂志,2015,54(5):445-451.
[14]陈伦虎,赵华,罗寿军,等.马来酸曲美布汀联合谷维素治疗肠易激综合征的疗效观察[J].西部医学,2011,23(11):2164-2165,2167.

相似文献/References:

[1]唐庆林,宫秀群,冯根宝,等.肠易激综合征大鼠内脏高敏感性与脑肠互动的研究[J].医学研究与战创伤救治(原医学研究生学报),2012,14(01):1.
 TANG Qing-lin,GONG Xiu-qun,FENG Gen-bao,et al.The investigation of the relation between visceral hypersensitivity and brain-gut interaction in the rat model with irritable bowel syndrome[J].JOURNAL OF MEDICALRESEARCH —COMBAT TRAUMA CARE,2012,14(04):1.

备注/Memo

备注/Memo:
-
更新日期/Last Update: 2016-07-20